Latest Breaking News On - Thomask equels - Page 12 : comparemela.com

AIM ImmunoTech to Present at the H C Wainwright 25th Annual Global Investment Conference

AIM ImmunoTech to Present at the H C Wainwright 25th Annual Global Investment Conference
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

United statesNew yorkJenene thomasThomask equelsImmunotech incChief executive officerAnnual global investment conferenceInvestor contact

AIM ImmunoTech Rejects Director Nomination Notice from Activist Group Due to Numerous Material Defects, Omissions and False and Misleading Statements

AIM ImmunoTech Rejects Director Nomination Notice from Activist Group Due to Numerous Material Defects, Omissions and False and Misleading Statements
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesThomask equelsTodd deutschJonathant jorglJenene thomasTedd kellnerNancy bryanMichael riceJoe germani dan zaccheiWalteri lautzFranzn tudorMichaelj xirinachsRobertl chioiniImmunotech incCompany bylawsCompany bylaws the

AIM ImmunoTech Inc : AIM ImmunoTech Reports Second Quarter Financial Results and Provides Clinical Pipeline Update

AIM ImmunoTech Inc : AIM ImmunoTech Reports Second Quarter Financial Results and Provides Clinical Pipeline Update
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesSouth africaSouth africanThomask equelsAstrazeneca imfinziChristopher mcaleerErasmus medical centerCompany phaseAmerican journal of cancer researchEarly access programCompany on twitterImmunotech incUniversity of nebraskaTrademark officeChief executive officerAmerican journal

AIM ImmunoTech Reports Second Quarter Financial Results and Provides Clinical Pipeline Update

– Continued operational execution across pipeline towards multiple clinical and regulatory value-driving milestones expected in the second half of 2023 – Company to host conference call and. -Today at 06:46 am- MarketScreener

United statesSouth africaSouth africanAstrazeneca imfinziThomask equelsChristopher mcaleerImmunotech incUniversity of nebraskaTrademark officeCompany phaseErasmus medical centerAmerican journal of cancer researchEarly access programChief executive officerAmerican journalCancer research

AIM ImmunoTech to Discuss Second Quarter 2023 Financial Results on August 15, 2023, and Host Conference Call and Webcast

OCALA, Fla., Aug. 09, 2023 AIM ImmunoTech Inc. announced today that management will host a conference call and webcast to discuss the Company’s Q2 2023 operational and financial results on.

United statesChristopher mcaleerThomask equelsImmunotech incCompany on twitterChief executive officerTech conference